This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Haruki Hasegawa, PhD
Scientific Director at Amgen
Speaker

Profile

Haruki is a molecular cell biologist specializing in intracellular folding and trafficking of therapeutically important proteins. After receiving a Ph.D. in Molecular Cell Biology from the University of Michigan, Haruki undertook a postdoctoral training at the National Institutes of Health (NIH/NICHD), Bethesda, MD. His first pharma experience came from the Assay Development group in Bayer’s Kyoto Research Center. For the last 16+ years in Amgen’s Biologic Therapeutic Discovery Organization, Haruki works closely with cross-functional teams to advance early-stage exploratory programs from target validation and proof-of-concept studies to biologics lead selection and early development.

Agenda Sessions

  • Understanding the Biosynthesis of Human IgM through a Combinatorial Expression of Mutant Subunits that Affect Product Assembly and Secretion

    11:45